CLINICAL_TRIALS
other
· 2025-06-27
Clinical Trial Update: Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients [Phase 3]
Summary
Phase 3 study evaluating fecal microbiota transplantation for severe irritable bowel syndrome is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: NOT_YET_RECRUITING